CRISPR-Cas9-based screening and engineering of novel biologics to target the vulnerabilities of primary and recurrent glioblastoma

Glioblastoma (GBM) is the most common primary adult brain tumor. Even with surgery, standard chemotherapy, and radiation, tumor recurrence and patient relapse are inevitable with a median survival rate of

Intern: 
Chirayu Chokshi
Martin Soste
Leonie Enderle
Nazanin Tatarin
Faculty Supervisor: 
Sheila Kumari Singh
Sachdev Sidhu
Jason Moffat
Province: 
Ontario
University: 
Partner University: 
Program: